Search This Site!
Skip to Page Content
ISN Profiles
ALPHABETICAL BY TEAMS
How to Volunteer
Active Volunteers (Main List)
Enrolling or Rep Form
Inactive Volunteers
On Leave, Update, Retired
Board of Directors
Development/Fundraising
Medical Advisory Board
Newsroom Team
Publishing
Support
Translations
Website
Volunteer Services
Ways You Can Help
Shinichi Sato, M.D., Ph.D.
ISN Medical Advisory Board

Dr. Shinichi SatoDr. Shinichi Sato, M.D., Ph.D. is Professor of Dermatology at Nagasaki University Graduate School of Medicine in Japan.

He graduated from the University of Tokyo in 1989 and since then, he has been joining scleroderma clinics in both the University of Tokyo and Kanazawa University. He has been investigating clinical aspects and immunologic abnormalities associated with scleroderma. Because he was a Research Associate in the Department of Immunology, Duke University Medical Center between 1994-1997, and studied molecular and cellular immunology of B lymphocytes, he is now actively investigating B lymphocyte abnormalities in SSc and trying to develop a novel therapeutic strategy for B lymphocytes. In 2003, he received the award of the Japanese Society of Investigative Dermatology, regarding B lymphocyte abnormalities of scleroderma.

He is also an Investigator in Elucidation of Pathogenesis and Development of Disease-Modifying Therapy in Scleroderma held by Ministry of Health, Labour and Welfare of Japan.

Shinichi Sato, MD, PhD
Department of Dermatology
Nagasaki University Graduate School of Medicine, 1-7-1
Sakamoto Nagasaki 852-8501
Office Phone: 81-95-849-7331
Fax: 81-95-849-7335

Email:shinichi-sato@sclero.org

Related Links
B lymphocytes and systemic sclerosis. B cells may have more pathogenic roles in systemic sclerosis than had been appreciated. Collectively, B cells and B-cell-specific response regulators such as CD19/CD22 appear to be potential therapeutic targets of the disease. PubMed. Curr Opin Rheumatol. 2005 Nov;17(6):746-51. (Also see: Causes of Scleroderma: B Cells and T Cells)
New ISN Japanese Brochure: What is Scleroderma?
Japanese BrochureJapanese: What is Scleroderma? Brochure. This new PDF brochure was translated from the ISN English brochure by Yoko, medically edited by Dr. Shinichi Sato, and desktop published by Susanne Piché. (Also see: Scleroderma from A to Z: Japanese Version) Posted 10-03-05.
Localized scleroderma is an autoimmune disorder. Many previous studies conclude that localized scleroderma involves autoimmune abnormalities and is one of the organ-specific autoimmune disorders targeting mainly skin, although the types of autoimmune abnormality are different from systemic sclerosis. PubMed. Rheumatology (Oxford). 2004 Nov 23. (Also see: Types of Scleroderma: Localized, Morphea, Linear, and Dr. Shinichi Sato)
ISN Medical Advisory Board
Dr. James R. Seibold, Chair
Dr. Luis Catoggio, Argentina
Dr. C. Stephen Foster, U.S.
Dr. Hsiao-Yi Lin, Taiwan
Dr. Tafazzul Mahmud, Pakistan
Dr. Matucci-Cerinic, Italy
Dr. Janet Pope, Canada
Dr. Shinichi Sato, Japan
Dr. James Seibold, Chair
Dr. van den Hoogen, Netherlands
Page Notes
Contact information updated, 07-11-06. SLE.
Keep on Surfing!
Go to Seibold, Dr. James R.
Since 1998, we have complied with the HONcode standard for health trustworthy information: verify here. The International Scleroderma Network (SCLERO.ORG) is a full-service nonprofit. Check our nonprofit status with Guidestar.org Please let us know how we can help you.
Warm Hugs,
Shelley Ensz, ISN Founder & President
Contact ISN
Inquiry Form (English) Mail-In Donation/Order Form Online Donation/Order Form
Inquiry Form (Spanish) Website: www.sclero.org Please contact us in English.
Email: isn@sclero.org or
webmaster@sclero.org
Or post a message in our Sclero Forums!
International Scleroderma Network
7455 France Ave So #266
Edina, MN 55435-4702 USA
Toll Free Hotline in U.S.
1-800-564-7099
Direct Line 952-831-3091 (U.S.)
The most important thing in the world to know about scleroderma is sclero.org!
© Copyright 1998-2008 International Scleroderma Network
All Rights Reserved